Acorn Bioventures, L.P.

Insider Reports History

Entity
Company
Location
295 Madison Avenue, 32 Nd Fl, New York, NY
Signature
ACORN BIOVENTURES, L.P., By: Acorn Capital Advisors GP, LLC, its general partner, By: /s/ Anders Hove, Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Acorn Bioventures, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Reneo Pharmaceuticals, Inc. 10%+ Owner Class A Common Stock 1.44M Oct 4, 2024 Direct

Insider Reports Filed by Acorn Bioventures, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 9, 2024 10%+ Owner